AI Science Tracker

Machine learning prioritizes compounds active against heterogeneous glioblastoma stem-cell models

University of Edinburgh; and Cancer Research UK Scotland Centre · 13 May 2026 · medicine

Discovery

Machine learning prioritizes compounds active against heterogeneous glioblastoma stem-cell models

Researchers trained cell-survival predictors on image-based screening data from six patient-derived glioblastoma stem-cell lines and screened more than 12,000 compounds. Experimental follow-up identified three compounds with activity across the GBM phenotype; HSP90 inhibitor XL-888 eliminated all six tested lines at nanomolar IC50 values, with analyses consistent with HSP90 inhibition and downstream client-protein disruption.

Technology: Machine-learning cell-survival predictors trained on high-throughput phenotypic screening

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: Experimental follow-up identified three compounds with activity across the GBM phenotype; HSP90 inhibitor XL-888 eliminated all six tested lines at nanomolar IC50 values, with analyses consistent with HSP90 inhibition and downstream client-protein disruption.
  • Still unknown: This is an in-vitro lead-discovery study across six patient-derived cell lines, not clinical efficacy. XL-888 is an existing HSP90 inhibitor and its proposed development as a GBM lead needs medicinal-chemistry optimization, including improved blood–brain-barrier penetration; no patient outcomes are reported.
  • AI role: ML models trained on in-house imaging/compound-response data predicted cell survival and prioritized compounds from a >12,000-compound screen; experimental assays across patient-derived GBM stem-cell models validated three leads and tested mechanisms. Researchers performed the wet-lab work and mechanism analyses.

Evidence sources: https://pubmed.ncbi.nlm.nih.gov/42158926/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.